Get in touch
We are keen to hear new ideas and discover assets that are relevant to our business. If you are interested in partnering with us, get in touch.
Contact us
Partnering at Grünenthal: Building a Future Together
Grünenthal has built a strong platform and unique capabilities to acquire, successfully integrate and maximize the performance of established brands and even entire portfolios. Since 2017, we have completed successful acquisitions of established brands worth more than € 2 billion and repeatedly outperformed the pharmaceutical market.
Partnering to grow our business and invest in the future
At Grünenthal we know that successful partnerships are all about respect, trust and commitment to collaboration. For every deal, big or small, we’re looking for like-minded partners who share our passion for bringing life-changing medicines to patients around the world.
As a fully integrated pharmaceutical company, our expertise and infrastructure cover R&D, manufacturing, quality control, supply, regulatory and commercial functions; this enables us to handle deals across the full lifecycle of a product.
Global Partnerships
60
countries
Strong network
50
partner companies
As we look to the future, partnering will continue to form a core element of our growth strategy, allowing us to:
- Foster Innovation with our industry-leading expertise in neurobiology, including sensory biology, hypersensitivity, neuroinflammation, and neurodegeneration. We seek to apply this expertise to promising compounds that may transform patients' lives.
- Diversify our commercial portfolio with established brands that address critical unmet medical needs
- Expand our global reach so we can serve more patients around the world
Why partner with us?
Patients are at the heart of everything we do, and we look forward to joining forces with you to make a meaningful difference and improve patients' lives!
By working with us, you gain a trusted, reliable and experienced partner who integrates seamlessly with your team to achieve the best outcome for both partners and, above all, the patients we serve. Together with you, we deliver best-in-class results in all aspects of a deal and its integration, from due diligence and negotiation to integration, manufacturing, supply and close partner management.
But what truly sets us apart is our people. For us, partnership means working side by side as equals. Our culture of collaboration, innovation, and entrepreneurial spirit is the foundation for strong, lasting relationships.
Our areas of partnering expertise
We have four key areas of expertise:
- M&A and subsequent asset integration: Our experienced team ensures seamless processes from due diligence to signature and provides end-to-end integration support, delivering on time, on budget, and without disruption to patient care
- R&D: We are always looking to strengthen our R&D pipeline through external innovation in pain and adjacent indications
- Partner business: By working with partners worldwide, we expand access to our portfolio, reaching more people with the life-changing medicines they need
- Contract manufacturing business: At Grünenthal, we offer full-service contract manufacturing and reliable supply for our partners. Our dedicated, flexible offerings are tailored to meet each partner’s specific needs. Find out more [here]
Our focus areas
At the same time, we take a therapy-agnostic approach to M&A deals around established brands — seeking promising, established brands that diversify and strengthen our existing commercial portfolio while immediately increasing our profitability and cash flow.
In terms of R&D, we are focused on leveraging our deep scientific expertise in pain and its pathophysiology – neurobiology, including sensory biology, hypersensitivity, neuroinflammation, and neurodegeneration – to drive innovation across the field and into adjacent therapeutic areas.
What do we bring to the table?
Our broad experience means we can support products of all sizes – from small and mid-sized to complex – at all stages of the lifecycle. And with dedicated resources at every stage of the deal process — from initial scouting to post-integration support and constant partner management — we offer seamless end-to-end partnership.
We don’t believe in a one-size-fits-all approach. Every product and geography are different, which is why we tailor distribution, marketing, and licensing strategies to fit the specific needs of each brand.
We’re proud of the strength and scale of our global network, with partnerships spanning over 100 countries. Thanks to our robust supply capabilities, we’ve maintained reliable product supply to patients at any time – from the COVID-19 pandemic through to today.
Who are we looking to collaborate with?
We’re always looking to collaborate with like-minded organisations – those that put patients first and uphold the same high ethical standards we hold ourselves to.
For Grünenthal, collaboration sits at the core of every partnership — and we are focused on diversifying our portfolio through collaborations that offer synergies with our infrastructure, commercial capabilities, and regulatory expertise.
In markets where we do not have our own footprint, we value working with those who bring deep market expertise and knowledge in the therapeutic areas of our products, and that help us gain insights into regions or therapeutic areas where we’re less active.
Ready to Collaborate? Let’s Talk.
If you are interested in partnering with us, we’d love to hear from you.
Our teams attend a range of conferences and events throughout the year, click here* to see where we will be, and how you can connect with us in person.
Prefer to get in touch directly? Use the form below to contact the relevant team based on your region and area of interest.
Want to learn more about our CMO offerings? Visit the Grünenthal Pro website to explore our capabilities.
M-N/A-DE-01-23-0007